Octreotide intended for oral administration in combination with other therapeutic agents

MA41159AUndetermined Publication Date: 2021-05-12CHIASMA INC +2

View PDF 0 Cites 0 Cited by

Patent Information

Application Number: MA41159
Authority / Receiving Office: MA · MA
Patent Type: Applications
Current Assignee / Owner
Priority Date: 2014-12-10
Filing Date: 2015-12-10
Publication Date: 2021-05-12

Application Information

Patent Timeline

10 Dec 2014

Priority

10 Dec 2015

Application

MA41159

12 May 2021

Publication

MA41159A

IPC: A61K31/135; A61K31/4745; A61K31/48; A61K38/08; A61K38/27; A61K38/31; A61K45/06; A61P5/06; C07K7/00

CPC: A61K38/08; C07K7/06; A61K38/31; A61K31/48; A61K38/27; A61P5/06; A61K2300/00; A61K31/135

Inventors: GELBAUM Dana; HAVIV Asi

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Need to check novelty before this filing date? Find Prior Art

No text content released.